Endoscopic diagnostics and treatment of esophagitis in patients after COVID-19

Abstract

A survey of 65 patients who had undergone COVID-19 and were admitted with a clinical picture of HH, reflux esophagitis was carried out. All patients underwent esophagogastroduodenoscopy, which was diagnosed with reflux esophagitis. According to the Los Angeles classification of esophagitis, grade C was diagnosed in 37 patients (56.9%), grade D in 28 patients (43.1%). In 43 patients (66.2%), there was a pronounced Hp contamination (+++), a moderately pronounced contamination (++) - in 22 patients (33.8%). The inclusion of exogenous nitric oxide in the complex therapy contributed to the eradication of Hp in 93.8% of patients and accelerated the epithelialization of erosions by 2.8-3.1 times compared with patients who did not receive nitric oxide in the complex therapy.